Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? - Strangfeld, A; Eveslage, M; Schneider, M (Ann Rheum Dis, 2011)
et al.